Navigation Links
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
Date:2/2/2010

GERMANTOWN, Md., Feb. 2 /PRNewswire/ -- Sensors for Medicine and Science, Inc., a clinical-stage, medical device company pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes, today announced the appointment of Dr. Paul Strumph as the company's Chief Medical Officer.

Dr. Strumph was most recently Vice President and Chief Medical Officer of the Juvenile Diabetes Research Foundation.  At JDRF, his responsibilities included overseeing the clinical research portfolio and providing direction on clinical programs for JDRF's therapeutic areas, and providing guidance to JDRF on regulatory policy and therapeutic delivery issues, such as reimbursement and provider acceptance.  He was also a member of the four-person Research Senior Management Team that set Research Strategy, and validated Program Area strategies and execution.  

Prior to JDRF, Dr. Strumph held leadership positions in Clinical and Medical Affairs with Bristol-Myers Squibb & Co., Merck KGaA and GlaxoSmithKline, including clinical development of products in the therapeutic areas of diabetes, obesity and cardiovascular disease.  This experience included advancing therapeutic compounds through Phase I – IV clinical studies.  

Prior to entering industry, Dr. Strumph was a practicing endocrinologist and Clinical Assistant Professor at the UNC Department of Medicine.  He received his medical degree with distinction in research, from the University of Rochester School of Medicine and Dentistry and is a diplomate of boards in Internal Medicine, Endocrinology, Diabetes & Metabolism, Pediatrics, and Pediatric Endocrinology.

"I am delighted to join Sensors for Medicine and Science and contribute to the development of this groundb
'/>"/>

SOURCE Sensors for Medicine and Science, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
2. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
3. GSK Announces Open Innovation Strategy to Help Deliver New and Better Medicines for People Living in the Worlds Poorest Countries
4. European Medicines Agency (EMA) Waives Requirement to Test StemEx(R) in Paediatric Patients 17 Years of Age and Under
5. Medco Partners with AmeriCares to Rush Donated Medicines to Help Victims of the Haiti Earthquake
6. STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine
7. Asthmatx Pivotal Trial Manuscript for Bronchial Thermoplasty Published in the American Journal of Respiratory and Critical Care Medicine
8. Cardiac Science and Gust Bardy, MD Create Innovation Center for Primary Care Medicine
9. World Renowned Physician and Thought Leader Dr. Eric J. Topol to Highlight Digital Medicine Revolution at International CES 2010
10. Obama Plan Buckles Under Pharma Lobby; Plan to Import Low-Cost Medicines Derails
11. Senate Rejects Bulk Imports of Medicine from Canada, but Personal Importation Remains a Popular Option for U.S. Citizens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... LONGMONT, Colo. , Aug. 27, 2015 /PRNewswire/ ... focused on the development of Next Generation ... for applications in high speed fiber-optic data ... Michael Lebby has been appointed to ... Lebby,s reputation in the field of optoelectronics is ...
(Date:8/27/2015)... and SOUTH SAN FRANCISCO, Calif. ... Fibrosis Foundation (PFF) and Veracyte, Inc. ... organizations are partnering on a U.S. patient survey ... interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis ... survey will assess the steps and time required ...
(Date:8/27/2015)... , Aug. 27, 2015  QB3@953—a ... a University of California (UC) research institute and ... company GSK to identify and facilitate collaborations to ... benefit patients. The agreement formalizes a ... Academia (DPAc) team and creates a new channel ...
Breaking Medicine Technology:Lightwave Logic Announces the Appointment of Optoelectronics Industry Leader, Michael Lebby, Ph.D. to its Board of Directors 2Lightwave Logic Announces the Appointment of Optoelectronics Industry Leader, Michael Lebby, Ph.D. to its Board of Directors 3Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 2Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 3Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 4QB3@953 Signs Collaboration Agreement with GSK to Identify Early-Stage Drug Discovery Opportunities 2
... Md., Sept. 13, 2011 Sodexo, Inc., a leader ... with Healthsense, Inc.  As a part of the agreement, ... existing senior living client communities – expanding Sodexo,s current ... Life for all of the people and communities they ...
... University of Michigan Health System has selected a new system-wide ... medical to communications devices, wireless phones and pagers for its ... Hospital. "Moving from a facility where numerous beds ... where beds are now separated into multiple rooms, we anticipated ...
Cached Medicine Technology:Sodexo Partners with Healthsense to Offer Seniors Technology-Enabled Solutions that Improve Quality of Daily Life 2Sodexo Partners with Healthsense to Offer Seniors Technology-Enabled Solutions that Improve Quality of Daily Life 3New Hospitals to Implement New Communications Technology 2
(Date:8/27/2015)... ... August 27, 2015 , ... ... scheduled for October 27-29, 2015 in San Jose, CA. The first event ... focus on the void that exists where battery development and energy storage innovation ...
(Date:8/27/2015)... ... , ... In addition to its existing Doctor of Philosophy in Leadership and ... its main campus in Reading: Doctor of Nursing Practice. , Alvernia’s Doctor of ... nurses for the highest level of clinical nursing practice. , “Our vision is ...
(Date:8/27/2015)... ... ... North Pinellas, located at 1395 South Pinellas Avenue in Tarpon Springs, will open a free-standing ... located at US Highway 19 North and Highlands Boulevard, less than eight miles from the ... project is slated to begin in September 2015. , The new 24-bed facility ...
(Date:8/27/2015)... ... August 27, 2015 , ... NetDimensions is once again named ... the platforms required not only to effectively deliver, curate and administer great programs, but ... Inc. , For six consecutive years, NetDimensions has maintained its position on this ...
(Date:8/27/2015)... ... 27, 2015 , ... Z-Medica®, LLC, a leading developer and ... website http://www.Z-Medica.com , to further support the company’s corporate positioning. , The ... , “We launched a branded website last year to show our customers ...
Breaking Medicine News(10 mins):Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3Health News:Z-Medica® Launches New Corporate Website 2
... England, both in terms of lives and money nearly ... report published today by the All Party Parliamentary Group (APPG) ... Lives - concludes that, despite effective treatments, there are 365 ... with unnecessary seizures, and 74,000 people are taking anti-epilepsy drugs ...
... tentative agreement with Delmont Laboratory to introduce its immunotherapeutic ... . According to this initial agreement, Delmont Laboratory will ... manufactures for the final packaging in China. ... agreement is to be signed. This product requires a ...
... data from its Phase IIb study in Alzheimer's disease (AD) ... and treated as diabetes of the brain. ... of amyloid beta plaques in the brain, yet recent research ... the brains of mice gives rise to some of the ...
... Diagnostics today announces that it has completed its ... with BioVeris for approximately $600 million on April ... Diagnostics now owns the patents for Electrochemiluminescence (ECL) ... the human diagnostics field into new market segments ...
... confirmed that the potentially lethal H5N1 strain of bird flu ... the country, the second such incident here in a week. ... the area around Frohburg, near Liepzig, second incidence of the ... ,The discovery followed the confirmation on Sunday of ...
... that air pollution affects women more than men . ... groups of mice with pneumonia. One group was exposed ... filtered air. ,The exposure to ozone significantly ... compared to males, reported science portal SCIENCE A GoGo. ...
Cached Medicine News:Health News:Blunders in Epilepsy Care Cost Lives, and Money UK Report 2Health News:Experimental Drug Ketasyn(TM) (AC-1202) Treats Alzheimer's as Diabetes of the Brain 2
Inquire...
Inquire...
Inquire...
... three styles. Each style has multiple sizes. ... popular style. Pectoral Implants are available non-sterile ... individually, not in pairs. Both styles are ... for a specific side and are directional. ...
Medicine Products: